Cardiometabolic characteristics of study subjects in the four growth groups.
. | Mismatch . | FGD-only . | RPWG-only . | Reference . |
---|---|---|---|---|
. | n = 85 . | n = 113 . | n = 186 . | n = 413 . |
Anthropometry and adiposity outcomes | ||||
6-y z-BMI (SDS) (n = 674) | 0.18 ± 1.26 | −0.16 ± 1.57 | 0.66 ± 1.59 | −0.29 ± 1.06 |
6-y z-height (SDS) (n = 674) | 0.50 ± 1.05 | −0.33 ± 1.00 | 0.45 ± 0.97 | −0.30 ± 0.85 |
6-y body fat % (n = 310) | 19.36 ± 5.47 | 19.65 ± 8.24 | 23.57 ± 7.67 | 18.94 ± 5.36 |
4.5-y SAT (mL) (n = 262) | 590.32 ± 293.33 | 503.79 ± 337.84 | 807.90 ± 595.04 | 471.77 ± 197.19 |
4.5-y VAT (mL) (n = 262) | 200.07 ± 53.07 | 168.24 ± 52.15 | 220.07 ± 124.48 | 181.66 ± 51.82 |
4.5-y IMCL (% of water signal) (n = 227) | 0.48 ± 0.13 | 0.45 ± 0.20 | 0.55 ± 0.44 | 0.44 ± 0.21 |
4.5-y liver fat (% by weight) (n = 216) | 0.65 ± 0.40 | 0.52 ± 0.39 | 0.58 ± 0.40 | 0.53 ± 0.37 |
6-y metabolic outcomes | ||||
Fasting glucose (mmol/L) (n = 429) | 4.64 ± 0.43 | 4.57 ± 0.34 | 4.56 ± 0.33 | 4.51 ± 0.36 |
Fasting insulin (pmol/L) (n = 324) | 37.35 ± 23.08 | 26.56 ± 12.98 | 35.00 ± 24.66 | 26.69 ± 14.97 |
HOMA-IR (units) (n = 323) | 1.17 ± 0.88 | 0.78 ± 0.40 | 1.03 ± 0.74 | 0.77 ± 0.45 |
6-y cardiovascular outcomes | ||||
cIMT (mm) (n = 422) | 0.43 ± 0.04 | 0.42 ± 0.03 | 0.42 ± 0.03 | 0.42 ± 0.03 |
PWV (m/s) (n = 443) | 4.82 ± 1.10 | 5.25 ± 2.24 | 4.91 ± 1.48 | 4.90 ± 1.58 |
SBP (mmHg) (n = 565) | 102.80 ± 8.32 | 101.90 ± 9.25 | 101.48 ± 8.48 | 100.23 ± 8.12 |
DBP (mmHg) (n = 565) | 61.98 ± 6.86 | 59.83 ± 5.39 | 59.81 ± 5.49 | 59.16 ± 5.48 |
. | Mismatch . | FGD-only . | RPWG-only . | Reference . |
---|---|---|---|---|
. | n = 85 . | n = 113 . | n = 186 . | n = 413 . |
Anthropometry and adiposity outcomes | ||||
6-y z-BMI (SDS) (n = 674) | 0.18 ± 1.26 | −0.16 ± 1.57 | 0.66 ± 1.59 | −0.29 ± 1.06 |
6-y z-height (SDS) (n = 674) | 0.50 ± 1.05 | −0.33 ± 1.00 | 0.45 ± 0.97 | −0.30 ± 0.85 |
6-y body fat % (n = 310) | 19.36 ± 5.47 | 19.65 ± 8.24 | 23.57 ± 7.67 | 18.94 ± 5.36 |
4.5-y SAT (mL) (n = 262) | 590.32 ± 293.33 | 503.79 ± 337.84 | 807.90 ± 595.04 | 471.77 ± 197.19 |
4.5-y VAT (mL) (n = 262) | 200.07 ± 53.07 | 168.24 ± 52.15 | 220.07 ± 124.48 | 181.66 ± 51.82 |
4.5-y IMCL (% of water signal) (n = 227) | 0.48 ± 0.13 | 0.45 ± 0.20 | 0.55 ± 0.44 | 0.44 ± 0.21 |
4.5-y liver fat (% by weight) (n = 216) | 0.65 ± 0.40 | 0.52 ± 0.39 | 0.58 ± 0.40 | 0.53 ± 0.37 |
6-y metabolic outcomes | ||||
Fasting glucose (mmol/L) (n = 429) | 4.64 ± 0.43 | 4.57 ± 0.34 | 4.56 ± 0.33 | 4.51 ± 0.36 |
Fasting insulin (pmol/L) (n = 324) | 37.35 ± 23.08 | 26.56 ± 12.98 | 35.00 ± 24.66 | 26.69 ± 14.97 |
HOMA-IR (units) (n = 323) | 1.17 ± 0.88 | 0.78 ± 0.40 | 1.03 ± 0.74 | 0.77 ± 0.45 |
6-y cardiovascular outcomes | ||||
cIMT (mm) (n = 422) | 0.43 ± 0.04 | 0.42 ± 0.03 | 0.42 ± 0.03 | 0.42 ± 0.03 |
PWV (m/s) (n = 443) | 4.82 ± 1.10 | 5.25 ± 2.24 | 4.91 ± 1.48 | 4.90 ± 1.58 |
SBP (mmHg) (n = 565) | 102.80 ± 8.32 | 101.90 ± 9.25 | 101.48 ± 8.48 | 100.23 ± 8.12 |
DBP (mmHg) (n = 565) | 61.98 ± 6.86 | 59.83 ± 5.39 | 59.81 ± 5.49 | 59.16 ± 5.48 |
Values in table are presented as mean ± SD or n (%). FGD, fetal growth deceleration; RPWG, rapid postnatal weight gain; BMI, body mass index; SDS, standard deviation score; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue; IMCL, intramyocellular lipid; HOMA-IR, homeostasis model assessment of insulin resistance; cIMT, carotid intima-media thickness; PWV, pulse wave velocity; SBP, systolic blood pressure; DBP, diastolic blood pressure.
Cardiometabolic characteristics of study subjects in the four growth groups.
. | Mismatch . | FGD-only . | RPWG-only . | Reference . |
---|---|---|---|---|
. | n = 85 . | n = 113 . | n = 186 . | n = 413 . |
Anthropometry and adiposity outcomes | ||||
6-y z-BMI (SDS) (n = 674) | 0.18 ± 1.26 | −0.16 ± 1.57 | 0.66 ± 1.59 | −0.29 ± 1.06 |
6-y z-height (SDS) (n = 674) | 0.50 ± 1.05 | −0.33 ± 1.00 | 0.45 ± 0.97 | −0.30 ± 0.85 |
6-y body fat % (n = 310) | 19.36 ± 5.47 | 19.65 ± 8.24 | 23.57 ± 7.67 | 18.94 ± 5.36 |
4.5-y SAT (mL) (n = 262) | 590.32 ± 293.33 | 503.79 ± 337.84 | 807.90 ± 595.04 | 471.77 ± 197.19 |
4.5-y VAT (mL) (n = 262) | 200.07 ± 53.07 | 168.24 ± 52.15 | 220.07 ± 124.48 | 181.66 ± 51.82 |
4.5-y IMCL (% of water signal) (n = 227) | 0.48 ± 0.13 | 0.45 ± 0.20 | 0.55 ± 0.44 | 0.44 ± 0.21 |
4.5-y liver fat (% by weight) (n = 216) | 0.65 ± 0.40 | 0.52 ± 0.39 | 0.58 ± 0.40 | 0.53 ± 0.37 |
6-y metabolic outcomes | ||||
Fasting glucose (mmol/L) (n = 429) | 4.64 ± 0.43 | 4.57 ± 0.34 | 4.56 ± 0.33 | 4.51 ± 0.36 |
Fasting insulin (pmol/L) (n = 324) | 37.35 ± 23.08 | 26.56 ± 12.98 | 35.00 ± 24.66 | 26.69 ± 14.97 |
HOMA-IR (units) (n = 323) | 1.17 ± 0.88 | 0.78 ± 0.40 | 1.03 ± 0.74 | 0.77 ± 0.45 |
6-y cardiovascular outcomes | ||||
cIMT (mm) (n = 422) | 0.43 ± 0.04 | 0.42 ± 0.03 | 0.42 ± 0.03 | 0.42 ± 0.03 |
PWV (m/s) (n = 443) | 4.82 ± 1.10 | 5.25 ± 2.24 | 4.91 ± 1.48 | 4.90 ± 1.58 |
SBP (mmHg) (n = 565) | 102.80 ± 8.32 | 101.90 ± 9.25 | 101.48 ± 8.48 | 100.23 ± 8.12 |
DBP (mmHg) (n = 565) | 61.98 ± 6.86 | 59.83 ± 5.39 | 59.81 ± 5.49 | 59.16 ± 5.48 |
. | Mismatch . | FGD-only . | RPWG-only . | Reference . |
---|---|---|---|---|
. | n = 85 . | n = 113 . | n = 186 . | n = 413 . |
Anthropometry and adiposity outcomes | ||||
6-y z-BMI (SDS) (n = 674) | 0.18 ± 1.26 | −0.16 ± 1.57 | 0.66 ± 1.59 | −0.29 ± 1.06 |
6-y z-height (SDS) (n = 674) | 0.50 ± 1.05 | −0.33 ± 1.00 | 0.45 ± 0.97 | −0.30 ± 0.85 |
6-y body fat % (n = 310) | 19.36 ± 5.47 | 19.65 ± 8.24 | 23.57 ± 7.67 | 18.94 ± 5.36 |
4.5-y SAT (mL) (n = 262) | 590.32 ± 293.33 | 503.79 ± 337.84 | 807.90 ± 595.04 | 471.77 ± 197.19 |
4.5-y VAT (mL) (n = 262) | 200.07 ± 53.07 | 168.24 ± 52.15 | 220.07 ± 124.48 | 181.66 ± 51.82 |
4.5-y IMCL (% of water signal) (n = 227) | 0.48 ± 0.13 | 0.45 ± 0.20 | 0.55 ± 0.44 | 0.44 ± 0.21 |
4.5-y liver fat (% by weight) (n = 216) | 0.65 ± 0.40 | 0.52 ± 0.39 | 0.58 ± 0.40 | 0.53 ± 0.37 |
6-y metabolic outcomes | ||||
Fasting glucose (mmol/L) (n = 429) | 4.64 ± 0.43 | 4.57 ± 0.34 | 4.56 ± 0.33 | 4.51 ± 0.36 |
Fasting insulin (pmol/L) (n = 324) | 37.35 ± 23.08 | 26.56 ± 12.98 | 35.00 ± 24.66 | 26.69 ± 14.97 |
HOMA-IR (units) (n = 323) | 1.17 ± 0.88 | 0.78 ± 0.40 | 1.03 ± 0.74 | 0.77 ± 0.45 |
6-y cardiovascular outcomes | ||||
cIMT (mm) (n = 422) | 0.43 ± 0.04 | 0.42 ± 0.03 | 0.42 ± 0.03 | 0.42 ± 0.03 |
PWV (m/s) (n = 443) | 4.82 ± 1.10 | 5.25 ± 2.24 | 4.91 ± 1.48 | 4.90 ± 1.58 |
SBP (mmHg) (n = 565) | 102.80 ± 8.32 | 101.90 ± 9.25 | 101.48 ± 8.48 | 100.23 ± 8.12 |
DBP (mmHg) (n = 565) | 61.98 ± 6.86 | 59.83 ± 5.39 | 59.81 ± 5.49 | 59.16 ± 5.48 |
Values in table are presented as mean ± SD or n (%). FGD, fetal growth deceleration; RPWG, rapid postnatal weight gain; BMI, body mass index; SDS, standard deviation score; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue; IMCL, intramyocellular lipid; HOMA-IR, homeostasis model assessment of insulin resistance; cIMT, carotid intima-media thickness; PWV, pulse wave velocity; SBP, systolic blood pressure; DBP, diastolic blood pressure.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.